ACCC seeks HCC patient treated with STRIDE

[AndreaWilson_Founder]

The Association of Cancer Care Centers (ACCC) is seeking an HCC patient treated with the STRIDE regimen (tremelimumab + durvalumab), who is willing to be interviewed for a podcast.

Compensation is provided for your time. Please email Andrea at [e-mail] for more information.

Thank you!

~Andrea Wilson Woods

President & Founder, Blue Faery